Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Science Advances|February 20, 2021
Patient-tailored design for selective co-inhibition of leukemic cell subpopulationsAleksandr Ianevski, Jenni Lahtela, Komal K Javarappa, et al.
Molecular Oncology|September 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemiaJoseph Saad, Rhiannon Newman, Elmira Khabusheva, et al.
Nature Communications|October 3, 2024
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clonesAleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
European Journal of Human Genetics : EJHG|July 5, 2025
Estimating the use of biological samples in Finnish biobanks and hospital collectionsAaro Tupasela, Tom Southerington, Johanna Mäkelä, et al.
Molecular Cancer Therapeutics|April 1, 2024
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic WindowTero Satomaa, Henna Pynnönen, Olli Aitio, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.
Blood|October 2, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trialSari Kytölä, Ida Vänttinen, Tanja Ruokoranta, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Haematologica|December 15, 2022
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemiaHeikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, et al.
Pageof 4